Richard Josephson, MD
- Medical Director, CICU, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
- Medical Director, CVP Rehabilitation, UH Cleveland Medical Center
- Aortic Valve Disease
- Atrial Fibrillation
- Cardiac Arrhythmias
- Cardiac Rehabilitation
- Cardiovascular Diseases
- Chest Pain
- Congestive Heart Failure (CHF)
- Coronary Artery Disease (CAD)
- Mitral Valve Disease
- Myocardial Infarction
- Pericardial Disease
- Pericardial Effusion
- Preoperative Cardiac Evaluation
- Preventive Cardiovascular Medicine
- Valvular Heart Disease
- Ventricular Arrhythmia
Patient Satisfaction Reviews
4.7 out of 5
Patient Comments (4)
Reviewed On 3/22/2020
very caring Dr. and he has solved my BP problems.
Reviewed On 12/16/2019
excellent office attention
Reviewed On 9/29/2019
just a fantastic Physician with a wonderful bedside manner who relates information and knows how to explain any the answer to any question I may have. [...] he is the best anybpatient could have. A very calming bedside manner.
Reviewed On 8/18/2019
Dr. Josephson asked for some additional information that I did not have with me, he gave me his personal (hospital direct) email address. Upon returning home I immediately sent the info, within 10 minutes he replied, to me it was obvious he had read what I had sent him and he replied. VERY IMPRESSIVE!!
- Cardiovascular Disease - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Research Fellowship | Cardiovascular Disease
Cardiovascular Disease - National Institutes Of Health (1985 - 1988)
Fellowship | Cardiovascular Disease
Cardiovascular Disease - Johns Hopkins Hospital (1985 - 1988)
Residency | Internal Medicine
Internal Medicine - Johns Hopkins Bayview Medical Center (1983 - 1985)
Internship | Internal Medicine
Internal Medicine - Johns Hopkins Bayview Medical Center (1982 - 1983)
New York University School Of Medicine And Langone Medical Center (1982)
New York University (1980)
University Of Rochester (1977)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Richard Josephson did not disclose any Outside Relationships with Industry.